ATE2090T1 - Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel. - Google Patents

Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel.

Info

Publication number
ATE2090T1
ATE2090T1 AT80401111T AT80401111T ATE2090T1 AT E2090 T1 ATE2090 T1 AT E2090T1 AT 80401111 T AT80401111 T AT 80401111T AT 80401111 T AT80401111 T AT 80401111T AT E2090 T1 ATE2090 T1 AT E2090T1
Authority
AT
Austria
Prior art keywords
activator
plasminogen activator
manufacture
plasminogen
fibrin
Prior art date
Application number
AT80401111T
Other languages
English (en)
Inventor
Lucien Dr. Dussourd D'hinterland
Gerard Normier
Original Assignee
Pierre Fabre S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7919432A external-priority patent/FR2462165A2/fr
Application filed by Pierre Fabre S.A. filed Critical Pierre Fabre S.A.
Application granted granted Critical
Publication of ATE2090T1 publication Critical patent/ATE2090T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT80401111T 1979-07-27 1980-07-25 Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel. ATE2090T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7919432A FR2462165A2 (fr) 1973-12-03 1979-07-27 Procede perfectionne de preparation d'activateur du plasminogene

Publications (1)

Publication Number Publication Date
ATE2090T1 true ATE2090T1 (de) 1983-01-15

Family

ID=9228380

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80401111T ATE2090T1 (de) 1979-07-27 1980-07-25 Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel.

Country Status (7)

Country Link
US (1) US4314994A (de)
EP (1) EP0023860B1 (de)
JP (1) JPS5620596A (de)
AT (1) ATE2090T1 (de)
CA (1) CA1154671A (de)
DE (1) DE3061429D1 (de)
ES (1) ES494343A0 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2121050B (en) * 1979-07-05 1986-03-26 Genentech Inc Preparation of functional human urokinase proteins
FR2483234A2 (fr) * 1980-05-29 1981-12-04 Fabre Sa Pierre Composition ophtalmique contenant un activateur du plasminogene
FI831484L (fi) * 1982-05-05 1983-11-06 Genentech Inc Plasminogen aktivator foer maenskovaevnad
US5185259A (en) * 1982-05-05 1993-02-09 Genentech, Inc. Truncated human tissue plasminogen activator
US4853330A (en) * 1983-04-07 1989-08-01 Genentech, Inc. Human tissue plasminogen activator
DE3348289C2 (de) * 1982-05-05 1994-05-05 Genentech Inc Verfahren zur Herstellung von Human-Gewebe-Plasminogen-Aktivator
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
US4766075A (en) * 1982-07-14 1988-08-23 Genentech, Inc. Human tissue plasminogen activator
MX197183A (es) * 1982-05-05 1994-02-28 Genentech Inc Activador de plasminogeno de tejido humano
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
DE3512910A1 (de) * 1985-04-11 1986-10-16 Behringwerke Ag, 3550 Marburg Verfahren zur reinigung von plasminogenaktivatoren
FI85334C (fi) * 1985-05-28 1992-04-10 Wellcome Found Foerfarande foer framstaellning av en vattenbaserad, vaevnadsplasminogenaktivator (t-pa) innehaollande, koncentrerad parenterad loesning.
US4929560A (en) * 1988-02-03 1990-05-29 Damon Biotech, Inc. Recovery of tissue plasminogen activator
US6207151B1 (en) * 1989-09-21 2001-03-27 Mitsui Chemicals Inc. Aqueous solution of t-PA

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
FR2252842B1 (de) * 1973-12-03 1977-11-04 Fabre Sa Pierre
FR2347048A2 (fr) * 1976-04-07 1977-11-04 Choay Sa Compositions constituees par des composes du type plasminogene, notamment d'origine placentaire, procede d'obtention des ces compositions, et medicaments contenant ces compositions
FR2310133A2 (fr) * 1975-05-05 1976-12-03 Fabre Sa Pierre Nouveau medicament comportant un activateur du plasminogene perfectionne

Also Published As

Publication number Publication date
US4314994A (en) 1982-02-09
DE3061429D1 (en) 1983-01-27
EP0023860A2 (de) 1981-02-11
JPS5620596A (en) 1981-02-26
ES8106836A2 (es) 1981-10-01
EP0023860B1 (de) 1982-12-22
EP0023860A3 (en) 1981-02-18
CA1154671A (fr) 1983-10-04
ES494343A0 (es) 1981-10-01

Similar Documents

Publication Publication Date Title
ATE2090T1 (de) Verfahren zur herstellung eines plasminogenaktivators, so erhaltener aktivator und ihn enthaltendes arzneimittel.
ES525361A0 (es) Procedimiento para preparar un medicamento seguro contra hepatitis que contiene la proteina llamada inactivador cl.
GB1531558A (en) Compositions having affinity for hepatitis virus and method for hepatitis virus removal
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
DE3382723D1 (de) Adsorbens und Verfahren zu dessen Herstellung.
EP0142860A3 (en) Desulfatohirudine, process for its preparation and pharmaceutical agent
GR79989B (de)
HK1003227A1 (en) Material of polysaccharides containing carboxal groups and a process for producing such polysaccharides
DK0447585T3 (da) Fremgangsmåde til fremstilling af et intravenøst tolerant immunglobulin-G-præparat
SE8009157L (sv) Sett att framstellning hogrenade koncentrat av protrombinkomplex, de erhallna koncentraten och framstellning derav
ATE138590T1 (de) Pyrogensorbentmittel
GB1527268A (en) Antiserum for the quantitative determination of the decomposition products x and y of fibrin and fibrinogen
ATE4223T1 (de) Verfahren zum binden eines biologisch aktiven materials, zum beispiel eines proteins, an einen hydroxylgruppen enthaltenden traeger.
ES2034285T3 (es) Procedimiento de obtencion de principios tanicos de origen vegetal, composicion cosmetologica y composicion farmaceutica que contienen el principio tanico purificado obtenido segun el procedimiento.
DE2961609D1 (en) Sila-substituted 1,4-dihydropyridine derivatives, processes for their preparation, pharmaceutical compositions and process for their preparation
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
SE8600641L (sv) Nitrilofora eda-absorbenter
JPS5615215A (en) Preparation of human immunoglobulin for intravenous injection with immobilized pepsin gel
FI903197A0 (fi) Menetelmä S-proteiinipitoisen farmaseuttisen tuotteen valmistamiseksi
ATE12779T1 (de) Verfahren zur herstellung eines antithrombinheparin-komplexes sowie diesen komplex enthaltende pharmazeutische mischungen.
DE3779125D1 (de) Reinigungsmethode fuer antikoerper.
SE8304821L (sv) Arabinogalaktaner, deras framstellning och kompositioner innehallande desamma
SU542762A1 (ru) Способ выделени инвертазы из дрожжей
ATE137487T1 (de) Komplexe, enthaltend s(+)-phenyl-alkansäuren und alpha-hydroxy-alkansäuren
ATE110260T1 (de) Verfahren zur herstellung fester pharmazeutischer zubereitungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee